I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shaib, Walid L.
120
results:
Format
Online (120)
Mediatypes
Articles (Online) (70)
Bookchapter (Online) (1)
OpenAccess-fulltext (49)
Sorted by: Relevance
Sorted by: Year
?
1
Phase II trial of nivolumab and metformin in patients with ..:
Akce, Mehmet
;
Farran, Batoul
;
Switchenko, Jeffrey M
...
Journal for ImmunoTherapy of Cancer. 11 (2023) 10 - p. e007235 , 2023
Link:
https://doi.org/10.1136/..
?
2
Impact of metformin on clinical outcomes in advanced hepato..:
Kang, Sandra
;
Khalil, Lana
;
McCook‐Veal, Ashley
...
Liver Cancer International. 4 (2023) 2 - p. 77-88 , 2023
Link:
https://doi.org/10.1002/..
?
3
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemot..:
Eshmuminov, Dilmurodjon
;
Aminjonov, Botirjon
;
Palm, Russell F.
...
Annals of Surgical Oncology. 30 (2023) 7 - p. 4431-4432 , 2023
Link:
https://doi.org/10.1245/..
?
4
Phase II randomised, double-blind study of mFOLFIRINOX plus..:
Shaib, Walid L.
;
Manali, Rupji
;
Liu, Yuan
...
European Journal of Cancer. 189 (2023) - p. 112847 , 2023
Link:
https://doi.org/10.1016/..
?
5
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline..:
Eshmuminov, Dilmurodjon
;
Aminjonov, Botirjon
;
Palm, Russell F.
...
Annals of Surgical Oncology. 30 (2023) 7 - p. 4417-4428 , 2023
Link:
https://doi.org/10.1245/..
?
6
A randomized phase 2 trial of nivolumab, gemcitabine, and c..:
Sahai, Vaibhav
;
Griffith, Kent A.
;
Beg, Muhammad S.
...
Cancer. 128 (2022) 19 - p. 3523-3530 , 2022
Link:
https://doi.org/10.1002/..
?
7
Sex-related disparities in outcomes of cholangiocarcinoma p..:
Ledenko, Matthew
;
Antwi, Samuel O.
;
Arima, Shiho
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
8
Survival Outcomes of Adjuvant Chemotherapy in Elderly Patie..:
Khalil, Lana
;
Gao, Xingyu
;
Switchenko, Jeffrey M
...
The Oncologist. 27 (2022) 9 - p. 740-750 , 2022
Link:
https://doi.org/10.1093/..
?
9
Impact of Tumor Side on Clinical Outcomes in Stage II and I..:
Akce, Mehmet
;
Zakka, Katerina
;
Jiang, Renjian
...
Frontiers in Oncology. 11 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
10
Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days ..:
Bryson, Evan
;
Sakach, Elizabeth
;
Patel, Urvi
...
Clinical Colorectal Cancer. 20 (2021) 2 - p. 153-160 , 2021
Link:
https://doi.org/10.1016/..
?
11
Evaluating the impact of the Patient Preference Assessment ..:
Hianik, Rachel S.
;
Owonikoko, Taofeek
;
Switchenko, Jeffrey
...
Psycho-Oncology. 30 (2021) 10 - p. 1739-1744 , 2021
Link:
https://doi.org/10.1002/..
?
12
A multi-center, single-arm, phase Ib study of pembrolizumab..:
Herting, Cameron J.
;
Farren, Matthew R.
;
Tong, Yan
...
Cancer Immunology, Immunotherapy. 70 (2021) 11 - p. 3337-3348 , 2021
Link:
https://doi.org/10.1007/..
?
13
High-Risk Features Are Prognostic in dMMR/MSI-H Stage II Co..:
Mohamed, Amr
;
Jiang, Renjian
;
Philip, Philip A.
...
Frontiers in Oncology. 11 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
14
Impact of high-risk features for stage II adenocarcinoma of..:
Akce, Mehmet
;
Zakka, Katerina
;
Penley, McKenna
...
Cancer Treatment and Research Communications. 27 (2021) - p. 100329 , 2021
Link:
https://doi.org/10.1016/..
?
15
Is adjuvant chemotherapy beneficial for stage II-III goblet..:
Zakka, Katerina
;
Williamson, Shayla
;
Jiang, Renjian
...
Surgical Oncology. 36 (2021) - p. 120-129 , 2021
Link:
https://doi.org/10.1016/..
1-15